Regina Scholz

TL;DR: In this paper, the authors present a review of the current state of the art and some of the future perspectives supported by advanced methods of the so-called nanotechnology, taking this increasing clinical experience carefully into account together with the huge amount of new biological data on heat response of cells and tissues, the approach of magnetic fluid hyperthermia (MFH) is nowadays more promising than ever before.

TL;DR: This paper presents the first clinical application of interstitial hyperthermia using magnetic nanoparticles in locally recurrent prostate cancer in patients with biopsy-proven local recurrence of prostate cancer following radiotherapy with curative intent, to the authors’ knowledge.

TL;DR: In this article, a new AC magnetic field therapy system for clinical application of magnetic fluid hyperthermia (MFH) is described with optimized magnetic nanoparticle preparations it will be used for target-specific glioblastoma and prostate carcinoma therapy.

TL;DR: Deep cranial thermotherapy using magnetic nanoparticles can be safely applied on glioblastoma multiforme patients, and is tolerated well by all patients with minor or no side effects.

TL;DR: The selective “remote inactivation” of cancer cells by an AC magnetic field has been demonstrated in vitro and endocytosis and hyperthermia efficacy of silan and dextran magnetite was investigated.